Top Markets
Coin of the day
Resverlogix Corp. Resverlogix Corp.

Resverlogix Corp.

RVX
Kedudukan dalam Saham #28673
Resverlogix Corporation is a biotechnology firm currently in advanced clinical... Resverlogix Corporation is a biotechnology firm currently in advanced clinical development, concentrating on developing treatments for illnesses where existing medical solutions are inadequate. The company's leading therapeutic compound is apabetalone (RVX-208), a selective small molecule designed to inhibit bromodomain and extra-terminal proteins. This compound is presently undergoing pivotal Phase III clinical trials for patients afflicted with conditions such as cardiovascular disease, diabetes, various stages of kidney disease (including end-stage renal disease), and neurodegenerative disorders. Furthermore, Resverlogix Corp. has forged an alliance with Eversana Life Science Services, LLC to support the forthcoming commercial rollout of apabetalone as a treatment for COVID-19 across the United States and Canada. The company's main office is located in Calgary, Canada.
Harga Saham
$0.07339369
Disegerakkan terakhir: 2026-08-18
Modal Pasaran
$25.24M
Perubahan (1 hari)
5.26%
Perubahan (1 tahun)
-9.55%
Negara
CA
Perdagangan Resverlogix Corp. (RVX)

Kategori

Sejarah pecahan saham untuk Resverlogix Corp. (RVX)
Saham Resverlogix Corp. (simbol: RVX) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Aug 19, 2026.
Satu saham RVX yang dibeli sebelum Aug 19, 2026 kini bersamaan dengan 0 saham RVX.
Senarai pecahan saham
Tahun Pecahan Gandaan Gandaan Kumulatif
Tidak cukup data untuk tarikh yang disediakan.
Pecahan saham untuk syarikat pesaing atau serupa
Syarikat Bilangan pecahan saham Gandaan Kumulatif Negara
1 x2
US
0 -
US
0 -
NL
1 x3
AU
0 -
CH